American Bio Medica Corporation (ABMC)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST
American Bio Medica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 0.73 | 0.91 | 2.22 | 4.15 | 3.66 | 3.87 | Upgrade
|
| Revenue Growth (YoY) | -63.75% | -58.84% | -46.52% | 13.46% | -5.60% | -21.20% | Upgrade
|
| Cost of Revenue | 0.87 | 1.11 | 1.67 | 2.91 | 2.47 | 2.58 | Upgrade
|
| Gross Profit | -0.15 | -0.19 | 0.55 | 1.24 | 1.18 | 1.29 | Upgrade
|
| Selling, General & Admin | 0.98 | 1.05 | 1.64 | 1.77 | 1.7 | 1.96 | Upgrade
|
| Research & Development | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.09 | Upgrade
|
| Operating Expenses | 1.07 | 1.14 | 1.73 | 1.86 | 1.78 | 2.05 | Upgrade
|
| Operating Income | -1.21 | -1.33 | -1.18 | -0.62 | -0.59 | -0.76 | Upgrade
|
| Interest Expense | -0.17 | -0.19 | -0.19 | -0.18 | -0.27 | -0.28 | Upgrade
|
| Interest & Investment Income | 0 | 0 | - | - | - | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.12 | 0.12 | 0.68 | 0 | 0.17 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -1.26 | -1.41 | -0.7 | -0.79 | -0.69 | -1.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.11 | - | - | - | - | - | Upgrade
|
| Asset Writedown | - | - | -0.1 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 0.34 | - | - | - | Upgrade
|
| Pretax Income | 0.85 | -1.41 | -0.46 | -0.79 | -0.69 | -1.03 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0 | 0 | -0.01 | 0 | Upgrade
|
| Net Income | 0.85 | -1.41 | -0.46 | -0.8 | -0.68 | -1.03 | Upgrade
|
| Net Income to Common | 0.85 | -1.41 | -0.46 | -0.8 | -0.68 | -1.03 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 48 | 43 | 36 | 33 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 48 | 43 | 36 | 33 | 30 | Upgrade
|
| Shares Change (YoY) | 6.91% | 12.29% | 20.26% | 9.32% | 8.01% | 3.09% | Upgrade
|
| EPS (Basic) | 0.02 | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 | Upgrade
|
| EPS (Diluted) | 0.02 | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 | Upgrade
|
| Free Cash Flow | -1.12 | -0.77 | -0.67 | -0.49 | 0.06 | -0.22 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.01 | 0.00 | -0.01 | Upgrade
|
| Gross Margin | -20.25% | -21.14% | 24.71% | 29.85% | 32.39% | 33.26% | Upgrade
|
| Operating Margin | -167.08% | -145.89% | -53.16% | -14.97% | -16.22% | -19.68% | Upgrade
|
| Profit Margin | 117.08% | -154.44% | -20.87% | -19.19% | -18.63% | -26.55% | Upgrade
|
| Free Cash Flow Margin | -153.99% | -84.12% | -30.34% | -11.74% | 1.59% | -5.68% | Upgrade
|
| EBITDA | -1.17 | -1.28 | -1.11 | -0.54 | -0.51 | -0.68 | Upgrade
|
| EBITDA Margin | -160.74% | -140.31% | -50.09% | -13.07% | -14.01% | -17.59% | Upgrade
|
| D&A For EBITDA | 0.05 | 0.05 | 0.07 | 0.08 | 0.08 | 0.08 | Upgrade
|
| EBIT | -1.21 | -1.33 | -1.18 | -0.62 | -0.59 | -0.76 | Upgrade
|
| EBIT Margin | -167.08% | -145.89% | -53.16% | -14.97% | -16.22% | -19.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.